Encouraging intrepreneurship in the pharmaceutical industry
This article was originally published in Scrip
Executive Summary
In January 1989 the business headlines across the US centered around one key story: George W Ebright, President and COO of pharmaceutical giant SmithKline Beckman Corporation, had abruptly resigned.